|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.160 +0.006 (+3.896%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 3,646 | (26,372) | (53,814) | (15,348) | (204,943) |
| Net Cash from / (used in) Investing Activities | (70,947) | (17,246) | (147,737) | (47,868) | 155,834 |
| Net Cash from / (used in) Financing Activities | (27,675) | 102,631 | 123,170 | 160,472 | (7,257) |
| Increase / (Decrease) in Cash & Cash Equivalents | (94,976) | 59,013 | (78,381) | 97,256 | (56,366) |
| Cash & Cash Equivalents at beginning of period | 128,098 | 60,198 | 142,440 | 40,457 | 97,513 |
| Effect of Foreign Exchange Rate Changes | 1,371 | 8,887 | (3,861) | 4,727 | (690) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 34,493 | 128,098 | 60,198 | 142,440 | 40,457 |
| Remarks: | Real time quote last updated: 19/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -47,969,000 |
| %Change | -42.861% |
| EPS / (LPS) | HKD -0.017 |
| NBV Per Share ($) | HKD -0.017 |